vs
Acadia Healthcare Company, Inc.（ACHC）与亚玛芬体育（AS）财务数据对比。点击上方公司名可切换其他公司
亚玛芬体育的季度营收约是Acadia Healthcare Company, Inc.的1.3倍（$1.1B vs $821.5M），亚玛芬体育净利率更高（1.8% vs -143.3%，领先145.2%），亚玛芬体育自由现金流更多（$92.2M vs $-179.5M）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
亚玛芬体育是芬兰跨国运动装备企业，总部位于赫尔辛基，成立于1950年。早年为涉足烟草贸易、航运、出版等领域的多元化工业集团，后逐步转型专注于体育用品的生产与营销，现有员工超9700人，2018年起成为中国安踏体育旗下子公司。
ACHC vs AS — 直观对比
营收规模更大
AS
是对方的1.3倍
$821.5M
净利率更高
AS
高出145.2%
-143.3%
自由现金流更多
AS
多$271.7M
$-179.5M
损益表 — Q4 FY2025 vs Q1 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $1.1B |
| 净利润 | $-1.2B | $19.0M |
| 毛利率 | — | 52.8% |
| 营业利润率 | -142.4% | 12.4% |
| 净利率 | -143.3% | 1.8% |
| 营收同比 | 6.1% | — |
| 净利润同比 | -3710.4% | — |
| 每股收益（稀释后） | $-12.98 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCAS
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | — | ||
| Q2 25 | $869.2M | — | ||
| Q1 25 | $770.5M | — | ||
| Q4 24 | $774.2M | — | ||
| Q3 24 | $815.6M | — | ||
| Q2 24 | $796.0M | — | ||
| Q1 24 | $768.1M | $1.1B |
净利润ACHCAS
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | — | ||
| Q2 25 | $30.1M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $68.1M | — | ||
| Q2 24 | $78.5M | — | ||
| Q1 24 | $76.4M | $19.0M |
毛利率ACHCAS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 52.8% |
营业利润率ACHCAS
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | 12.9% | 12.4% |
净利率ACHCAS
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 9.9% | 1.8% |
每股收益（稀释后）ACHCAS
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.74 | — | ||
| Q2 24 | $0.85 | — | ||
| Q1 24 | $0.83 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | — |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | — |
| 总资产 | $5.5B | — |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCAS
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — | ||
| Q1 24 | $77.3M | — |
总债务ACHCAS
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益ACHCAS
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $3.0B | — | ||
| Q1 24 | $2.9B | — |
总资产ACHCAS
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.3B | — | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.0B | — | ||
| Q3 24 | $5.9B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.5B | — |
负债/权益比ACHCAS
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $114.3M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $92.2M |
| 自由现金流率自由现金流/营收 | -21.8% | 8.8% |
| 资本支出强度资本支出/营收 | 11.3% | 2.1% |
| 现金转化率经营现金流/净利润 | — | 6.02× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | — |
8季度趋势，按日历期对齐
经营现金流ACHCAS
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | — | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | — | ||
| Q3 24 | $163.1M | — | ||
| Q2 24 | $171.1M | — | ||
| Q1 24 | $-321.3M | $114.3M |
自由现金流ACHCAS
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | $92.2M |
自由现金流率ACHCAS
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | 8.8% |
资本支出强度ACHCAS
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 18.5% | 2.1% |
现金转化率ACHCAS
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | 6.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
AS
| Americas2 | $409.6M | 39% |
| EMEA1 | $356.9M | 34% |
| Greater China3 | $205.6M | 20% |
| Asia Pacific4 | $78.2M | 7% |
